| Literature DB >> 32050964 |
Fabienne Teike Lüthi1,2, Mathieu Bernard3, Michel Beauverd3, Claudia Gamondi3,4, Anne-Sylvie Ramelet5, Gian Domenico Borasio3.
Abstract
BACKGROUND: Early identification of patients requiring palliative care is a major public health concern. A growing number of instruments exist to help professionals to identify these patients, however, thus far, none have been thoroughly assessed for criterion validity. In addition, no currently available instruments differentiate between patients in need of general vs. specialised palliative care, and most are primarily intended for use by physicians. This study aims to develop and rigorously validate a new interprofessional instrument allowing identification of patients in need of general vs specialised palliative care.Entities:
Keywords: Content validity; Identification; Instrument; Interprofessional; Item generation; Palliative care; Screening
Year: 2020 PMID: 32050964 PMCID: PMC7017473 DOI: 10.1186/s12904-020-0522-6
Source DB: PubMed Journal: BMC Palliat Care ISSN: 1472-684X Impact factor: 3.234
Fig. 1Delphi process flowchart with specialist palliative care healthcare professionals
Item generation process
| Development steps | Item selection | Results |
|---|---|---|
| Step 2: generate a set of items | Initial set 1 of items (first author) | 21 from GSF, SPICT and NECPAL© 17 from other instruments and expert recommendations 3 different ‘surprise’ questions |
| Initial set 2 of items (CICE) | 32 items selected from the initial set 11 new items added from the CICE clinical experience | |
| Categorisation of second set of items (CICE) | 25 items for general PC 18 items for specialised PC | |
| Step 3: review of initial set of items | Delphi round 1 (expert panel) | 3 items for general PC 2 items for specialised PC |
| Delphi round 2 (expert panel) | 7 items for general PC 6 items for specialised PC | |
| Delphi round 3 (expert panel) | 7 items for general PC 8 items for specialised PC |
Item selection
| Items | Round 1 M ± SD; | Round 2 M ± SD; |
|---|---|---|
| Surprise question 12 months | 4.1 ± 1.4; | |
| Surprise question 6 months | 5.0 ± 0.0; | |
| Surprise question months, weeks or days | 4.2 ± 0.8; | |
| PC required by healthcare professional | 3.2 ± 1.8; | 4.3 ± 1.0; |
| PC required implicitly or explicitly by patients or relatives | 3.5 ± 1.3; | |
| PC required by patients/relatives | 3.3 ± 1.4; | |
| Advanced illness, unstable symptoms | 3.8 ± 1.6; | |
| Advanced illness and/or diminishing response to aetiological treatments | 4.3 ± 0.5; | |
| Disease that cannot be treated, vital prognosis is underway | 4.0 ± 1.3; | |
| Decreased response to treatment | 1.7 ± 0.6; n = 3 | |
| At least one disturbing symptom | 2.6 ± 0.9; | 4.1 ± 0.8; |
| Decrease in general condition | 3.2 ± 1.3; n = 6 | 4.8 ± 0.5; |
| Poor or deteriorating performance status | 2.6 ± 0.8; n = 7 | 3.8 ± 0.8; |
| General functional decline | 1.9 ± 0.8; | 5.0 ± 0.0; n = 8 |
| Functional markers of decline | 2.5 ± 0.6; n = 4 | |
| Dependency on others for most care needs | ||
| Nutritional markers of decline | 1.8 ± 0.7; n = 8 | 4.0 ± 0.6; n = 4 |
| Significant weight loss | 2.0 ± 0.8; n = 4 | |
| Interruption of any vital support measures | 2.7 ± 0.8; n = 6 | 4.0 ± 0.8; n = 11 |
| Other markers of severity and extreme fragility | 2.0 ± 1.0; | 3.7 ± 0.7; n = 9 |
| Sentinel events | n = 0 | |
| ≥ 2 unscheduled hospitalizations | 1.8 ± 1.0; n = 9 | 3.9 ± 0.8; n = 9 |
| ≥ 2 concomitant diseases | ||
| Significant co-morbidity | 2.0 ± 1.1; n = 7 | 3.7 ± 0.9; n = 9 |
| Emotional distress | 1.8 ± 0.7; n = 8 | 3.7 ± 0.8; n = 6 |
| Specific population | 4.1 ± 1.1; n = 11 | 3.6 ± 1.6; n = 8 |
| Rapidly evolving illness | 3.2 ± 1.8; n = 5 | 3.8 ± 1.7; n = 8 |
| Need for complex and intense continuing care | 3.0 ± 1.5; n = 12 | 2.3 ± 1.0; n = 9 |
| Persistent and distressing symptoms | 4.4 ± 0.6; | |
| ≥ 3 symptoms > 5 on ESAS | 3.8 ± 1.5; n = 8 | 3.6 ± 1.5; |
| Uncontrolled pain | 3.2 ± 1.2; n = 9 | 4.3 ± 0.9; |
| Difficulties in assessing symptoms | 3.8 ± 0.9; | 3.5 ± 1.1; |
| Severe psychological and/or existential distress | 2.6 ± 1.0; n = 18 | 2.6 ± 1.2; |
| Request for assisted suicide or euthanasia | 1.4 ± 1.1; n = 8 | 2.2 ± 1.5; n = 6 |
| Psychosocial distress patient and/or relatives | 2.5 ± 0.9; n = 17 | 3.0 ± 1.1; n = 11 |
| Difficulties in integrating information about the disease and/or prognosis | 1.0 ± 0.0; n = 1 | |
| Lack or insufficient support from relatives | 2.0 ± 1.0; | |
| Social vulnerability | 2.0 ± 0.0; n = 1 | |
| Accompanying the patient is difficult | 1.4 ± 0.8; n = 7 | |
| Difficulties in communicating about therapeutic/care objectives | 1.8 ± 0.4; n = 6 | 2.0 ± 1.4; n = 8 |
| Significant disagreement, uncertainty or conflict | 2.5 ± 1.5; | 2.8 ± 1.4; |
| Need for support and/or second opinion for current decision-making | 1.9 ± 0.8; n = 9 | |
| Difficulties in writing advanced directives | n = 0 | |
| Specialised PC team required by healthcare professional | 3.6 ± 1.3; n = 5 | |
| Palliative sedation envisaged | 2.6 ± 1.3; | |
| Need for respite for the relatives | 1.3 ± 0.6; n = 3 | |
items kept for the instrument at each round
| Items kept after first round | Items kept after second round |
|---|---|
| General PC | |
| Surprise question 12 months | PC required by healthcare professional |
| PC required implicitly or explicitly by patients or relatives | At least one distressing symptom |
| Disease that cannot be treated, vital prognosis is underway | General functional decline |
| Interruption of any vital support measures | |
| Other markers of severity and extreme fragility | |
| ≥ 2 unscheduled hospitalizations | |
| Significant co-morbidity | |
| Emotional distress | |
| Specialised PC | |
| Persistent and distressing symptoms | Difficulties in assessing symptoms |
| Severe psychological and/or existential distress | |
| Psychosocial distress patient and/or relatives | |
| Difficulties in communicating about therapeutic/care objectives | |
| Significant disagreement, uncertainty or conflict | |
| Specialised PC team required by healthcare professional | |
| Palliative sedation envisaged | |